GlassScriptPhysician profile
Yifan Li
NPI 1942654314
$2,516.46
in general payments reported to CMS, 2019-2025
11 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.51 · 2022: $113 · 2023: $1,705 · 2024: $379 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,311 · Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,310.53 |
| Food and Beverage | $1,078.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,500.43 | 2023 | |
| Siemens Medical Solutions USA, INC. | $481.12 | 2021-2025 | Varian Ethos Treatment Planning, Truebeam, Edge |
| Novocure INC. | $270.74 | 2022-2025 | Optune, Optune Gio |
| Regeneron Healthcare Solutions, INC. | $54.60 | 2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $49.53 | 2025 | Enhertu, Tagrisso |
| Telix Pharmaceuticals | $37.08 | 2023 | Illuccix |
| Lantheus Medical Imaging, INC. | $27.80 | 2024 | |
| Accuray Incorporated | $27.11 | 2022 | |
| Monteris Medical Corporation | $26.69 | 2025 | Neuroblate |
| Novartis Pharmaceuticals Corporation | $22.15 | 2024 | |
| Sumitomo Pharma America, INC. | $19.21 | 2023 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yifan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.